Tate & Lyle broadens metabolic health reformulation

Tate & Lyle says growing interest in metabolic health is widening the formulation brief for mainstream food and drink producers, adding fibre, carbohydrates, calorie density, and blood-glucose response to the established objective of reducing sugar.

The ingredients group is positioning soluble fibre as one option for manufacturers trying to improve several nutritional measures at the same time. The approach is set out in its Future-Proofing Nutrition work and has been expanded through current discussion with product developers around the effect of GLP-1 awareness on consumer expectations.

Emma Cahill, global marketing director for sweeteners, fibres, and GLP-1 at Tate & Lyle, said consumers are looking beyond sugar content towards carbohydrate, fibre, and protein as they pay more attention to energy levels and glycaemic response. That broadens the ingredient brief from removing a component towards adding functional ingredients capable of supporting several objectives.

The challenge is that sugar performs far more than one role in most manufactured foods. Depending on the application, it can contribute sweetness, bulk, viscosity, moisture retention, browning, freezing behaviour, texture, and shelf stability. Removing part of it can therefore create several defects that have to be corrected elsewhere in a recipe.

Fibre becomes part of the engineering brief

Soluble fibre can help address some of those trade-offs because it can contribute solids and nutritional fibre while replacing part of the sugar or digestible carbohydrate content. Tate & Lyle also points to evidence around soluble fibre and post-meal blood-glucose response, although the claims available to a finished product depend on jurisdiction, ingredient, dose, and formulation.

The practical value changes substantially by category. A bakery formulation needs to account for dough handling, spread, colour development, moisture, softness, and shelf life. A beverage places greater emphasis on solubility, clarity, viscosity, flavour balance, stability, and tolerance of pasteurisation or other heat treatment.

Dairy applications add interactions with protein and minerals, while confectionery can depend on crystallisation, water activity, glass transition, and texture. An ingredient that produces an acceptable nutritional panel but destabilises the process or changes the eating experience has limited commercial value.

That is why suppliers increasingly combine ingredient sales with application development. Reformulation often requires changes across sweeteners, flavours, starches, hydrocolloids, fibres, water content, and processing conditions rather than a single ingredient swap. Pilot-plant trials remain essential before a recipe can move onto a production line.

Tate & Lyle’s July report argues that metabolic health is becoming a broader consideration as consumers, retailers, and policymakers look beyond isolated nutrients. The company identifies bakery, dairy, beverages, and confectionery among the categories where manufacturers can combine sugar reduction with fibre enrichment and other nutritional improvements.

The fibre-intake gap provides part of the commercial rationale. Tate & Lyle’s primary report cites average UK adult fibre consumption of 16.4g per day against a recommended intake of 30g. Adding fibre to foods already consumed regularly can therefore contribute towards higher intake, although fortifying a product does not remove the need to assess its overall nutritional composition.

GLP-1 medicines have accelerated consumer discussion around metabolic health even where shoppers do not use the drugs themselves. Appetite regulation, protein intake, blood glucose, fibre, satiety, and portion size have moved further into mainstream food conversation, creating demand for products that combine reduction claims with positive nutritional attributes.

That does not mean ordinary foods should be presented as substitutes for medical treatment. Manufacturers still have to remain within permitted nutrition and health claims and avoid implying medicinal effects that a conventional product has not been authorised to make.

For development teams, the more durable consequence is a more complicated specification. A project that previously asked for 20% less sugar may now require less sugar, fewer calories, more fibre, acceptable protein content, familiar taste, unchanged texture, stable processing, the same shelf life, and a finished cost the market can support.

Meeting those requirements simultaneously increases the appeal of ingredients capable of performing several functions. It also increases the amount of development work required because each formulation has a different tolerance for added fibre and a different set of interactions with sweeteners, fats, starches, proteins, and processing conditions.

Cost can become the final constraint even when the technology works. Higher-value fibres and additional functional ingredients raise the bill of materials, while reformulation can require sensory panels, nutritional analysis, revised labels, factory trials, and line time that would otherwise be used for commercial production.

The economics are easier where one ingredient helps solve several problems. A soluble fibre that contributes bulk while increasing fibre content and reducing the amount of sugar required may avoid the need for separate ingredients or more radical process changes. That advantage remains product-specific rather than universal.

Tate & Lyle’s latest discussion therefore reflects a change in the way healthier-product briefs are being written. Sugar reduction remains part of the work, but manufacturers are increasingly being asked to improve several nutritional measures without changing the basic characteristics that made a product commercially successful.

The result is a more demanding piece of food engineering. Ingredient functionality, process stability, sensory performance, nutrition, regulation, and cost all have to converge in the same formulation, leaving little value in a technically impressive claim that cannot survive the production line.